Results 241 to 250 of about 53,459 (315)

RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets

MedComm, Volume 7, Issue 3, March 2026.
RNA regulatory networks play a crucial role in the initiation and progression of cancer through various modes of RNA interactions. Notably, circulating RNAs have emerged as potential biomarkers, while targeted interventions in RNA regulatory networks facilitate precise therapeutic strategies. ABSTRACT Cancer is a global health challenge. The initiation
Xuan Yin, Zengkan Du, Shuya Jiang, Yan Liao, Changli Wang, Jiaqi Li, Haoling Zhang, Ting‐Ting Wei, Wangzheqi Zhang, Zui Zou   +9 more
wiley   +1 more source

Predicting high lymph node positivity risk factors in nasopharyngeal carcinoma patients: A multi-model approach. [PDF]

Medicine (Baltimore)
Liao H, He B, Yan F.
europepmc   +1 more source

Clinical Application of Peripheral Blood Biomarkers for Solid Tumors

MedComm, Volume 7, Issue 3, March 2026.
Peripheral blood biomarkers provide a minimally invasive, dynamic, and potentially more accurate means to obtain a comprehensive tumor profile. Technologies for detecting them are advancing, and with the help of artificial intelligence, they are being used more and more often for cancer diagnosis, prognostic assessment, and therapeutic monitoring ...
Xinru Tu, Mengyan Tu, Junfen Xu
wiley   +1 more source

TP53-dependent antitumor effects of DHODH Inhibition in nasopharyngeal carcinoma. [PDF]

Discov Oncol
Dong X, Zhang Y, Zhang Z, Liu T, Gu D.
europepmc   +1 more source

Chromatin Accessibility in Cancer: Biological Functions, Mechanisms, Therapeutic Potential, and Future Directions

MedComm, Volume 7, Issue 3, March 2026.
Cancer remains the leading cause of mortality worldwide, and drug resistance further underscores the urgent need for innovative therapeutic strategies. Chromatin, a stable yet highly dynamic nucleoprotein complex, serves as the primary carrier of genetic material in eukaryotic cells.
Wentao Xia, Min Jiang, Yefei Huang, Kun Ding, Yansu Chen   +4 more
wiley   +1 more source

Villin like suppresses nasopharyngeal carcinoma proliferation by downregulating MYC. [PDF]

Sci Rep
Wen Y, Zhou Z, Zhou Y, Huang Z.
europepmc   +1 more source

Safety and Efficacy of Lucitanib Plus Toripalimab in Advanced Solid Tumors Refractory to Standard Therapies: An Open‐Label, Multicenter, Phase II Study

MedComm, Volume 7, Issue 3, March 2026.
Lucitanib plus toripalimab showed manageable safety and encouraging antitumor activity in advanced solid tumors, particularly in PD‐1‐refractory nasopharyngeal carcinoma and recurrent endometrial carcinoma. Clinical responses were observed across subgroups regardless of prior immunotherapy.
Ting Zhou, Haishuang Sun, Gang Chen, Guoping Zhang, Jinsheng Wu, Shenhong Qu, Yaqian Han, Desheng Hu, Yang Ling, Yulong Zheng, Jian Liu, Lizhu Lin, Yongsheng Li, Jianji Pan, Yanyan Liu, Cuiying Wang, Guohong Fu, Jian Feng, Jianhua Shi, Huiming Cai, Meng Li, Fugen Li, Yinbin Wang, Li Zhang, Yunpeng Yang   +24 more
wiley   +1 more source

Hormonal and reproductive factors and risk of nasopharyngeal carcinoma in Chinese women: a case-control study. [PDF]

BMC Res Notes
Su XY, Schroder A, Tse LA, Yu IT, Xie SH.   +4 more
europepmc   +1 more source

[Errors in the diagnosis of malignant nasopharyngeal neoplasms].

Czasopismo stomatologiczne, 1969
openaire   +1 more source

Anti-Yo positive paraneoplastic limbic encephalitis associated with nasopharyngeal carcinoma: A rare case. [PDF]

Radiol Case Rep
Aytaç A, Kasapoglu H, Yanık Keyik B.
europepmc   +1 more source